CIPHER PHARMACEUTICALS INC's ticker is CPHRF and the CUSIP is 17253X105. A total of 24 filers reported holding CIPHER PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $676,000 | -4.5% | 185,300 | 0.0% | 0.13% | +2.3% |
| Q3 2016 | $708,000 | -35.8% | 185,300 | -12.3% | 0.13% | -44.9% |
| Q2 2016 | $1,103,000 | -8.1% | 211,300 | -15.5% | 0.24% | -6.3% |
| Q1 2016 | $1,200,000 | +2.4% | 250,000 | 0.0% | 0.25% | +9.6% |
| Q4 2015 | $1,172,000 | +43.6% | 250,000 | +13.6% | 0.23% | +45.6% |
| Q3 2015 | $816,000 | -52.2% | 220,000 | +10.0% | 0.16% | -34.7% |
| Q2 2015 | $1,707,000 | – | 200,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Raffles Associates | 447,800 | $1,659,000 | 1.74% |
| Grandeur Peak Global Advisors, LLC | 1,506,600 | $5,566,000 | 1.24% |
| MONTRUSCO BOLTON INVESTMENTS INC. | 1,920,607 | $7,091,000 | 0.61% |
| TAYLOR ASSET MANAGEMENT INC | 526,900 | $1,954,000 | 0.41% |
| ARMISTICE CAPITAL, LLC | 300,000 | $1,115,000 | 0.38% |
| INTACT INVESTMENT MANAGEMENT INC. | 734,900 | $3,601,000 | 0.16% |
| AWM Investment Company, Inc. | 220,000 | $816,000 | 0.16% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 638,000 | $2,356,000 | 0.05% |
| ACADIAN ASSET MANAGEMENT LLC | 739,684 | $2,729,000 | 0.02% |
| EverPoint Asset Management, LLC | 150,000 | $556,000 | 0.01% |